Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.

about

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.

P2860

Q47119800-1B8368B4-EA2D-418E-A3D1-5B62FD3722AD

P2860

Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.

Item

http://www.wikidata.org/entity/Q53723158

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@en

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@nl

type

Item

label

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@en

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@nl

prefLabel

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@en

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@nl

P1476

Liraglutide ameliorates cardio ...... Akt/GSK-3β signaling pathway.

@en

P2093

Noha A T Abbas

http://www.w3.org/2001/XMLSchema#string

Soad L Kabil

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin cardiomyopathy

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci

Domain-domain associations in cystic fibrosis transmembrane conductance regulator.

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

The role of the complement system in ischemia-reperfusion injury.

Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice

P2888

s00210-017-1414-z

P304

1145-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00210-017-1414-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

390

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28780599

http://www.w3.org/2001/XMLSchema#string

Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.

about

P2860

P2860

Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698